Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-4-26
pubmed:abstractText
To determine if photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, GA) can improve the chance of stabilizing or improving vision (<8 letter loss) safely in patients with subfoveal choroidal neovascularization (CNV) caused by pathologic myopia.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0161-6420
pubmed:author
pubmed:issnType
Print
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
841-52
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11320011-Adult, pubmed-meshheading:11320011-Aged, pubmed-meshheading:11320011-Choroidal Neovascularization, pubmed-meshheading:11320011-Contrast Sensitivity, pubmed-meshheading:11320011-Double-Blind Method, pubmed-meshheading:11320011-Female, pubmed-meshheading:11320011-Fluorescein Angiography, pubmed-meshheading:11320011-Follow-Up Studies, pubmed-meshheading:11320011-Fovea Centralis, pubmed-meshheading:11320011-Humans, pubmed-meshheading:11320011-Infusions, Intravenous, pubmed-meshheading:11320011-Male, pubmed-meshheading:11320011-Middle Aged, pubmed-meshheading:11320011-Myopia, pubmed-meshheading:11320011-Photochemotherapy, pubmed-meshheading:11320011-Photosensitizing Agents, pubmed-meshheading:11320011-Porphyrins, pubmed-meshheading:11320011-Safety, pubmed-meshheading:11320011-Treatment Outcome, pubmed-meshheading:11320011-Visual Acuity
pubmed:year
2001
pubmed:articleTitle
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Multicenter Study